Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gut microbiota and host intestinal mucosa constitute a dynamic ecosystem and physical barrier essential for maintaining systemic homeostasis. The microbiota, comprising bacteria, fungi, and viruses, performs critical metabolic functions such as the fermentation of non-digestible carbohydrates into short-chain fatty acids, which serve as energy for colonocytes (Nature Reviews Microbiology, 2016). The host mucosa acts as a selective barrier, utilizing a mucus layer, antimicrobial peptides, and a tight junction-linked epithelial layer to prevent the translocation of pathogens while allowing nutrient absorption (Science, 2017). Disruptions in this interface, known as dysbiosis or "leaky gut," are central to the pathogenesis of inflammatory bowel diseases, metabolic disorders, and certain cancers (Cell, 2020). Pharmacological and biotherapeutic interventions target this system by introducing beneficial microbes, providing prebiotic substrates, or using biologics to stabilize the host immune response at the mucosal surface.
Therapeutic strategies involve the modulation of microbial populations to reduce pro-inflammatory signals, the reinforcement of the intestinal epithelial barrier, and the induction of regulatory T-cell responses through microbial metabolites like short-chain fatty acids (SCFAs).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut microbiota and host intestinal mucosa.